Screening for pancreatic cancer in new diabetes patients
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study uses imaging tests like CT scans or endoscopic ultrasound to look for early signs of pancreatic cancer in people who have recently developed diabetes. It aims to find cancer early, when it might be easier to treat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 50 years.
- You have been diagnosed with diabetes based on blood sugar tests.
- Your blood sugar levels were normal or only slightly high in the past 6 to 18 months.
- You have a score above 2 on a special screening tool for pancreatic cancer risk.
- You do not have chronic pancreatitis, a history of pancreatic cancer, or are not taking steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan that uses a special tracer (FAPI) to get clearer images of pancreatic cancer. The goal is to find cancer earlier and better plan surgery or treatment.
This study checks if a simple blood test can find tiny bits of cancer DNA after your pancreatic surgery, which may help detect if cancer comes back earlier than scans. By joining, you'll help doctors learn how to better monitor the disease and guide future treatments.
This study screens people with recent diabetes who are at high risk for pancreatic cancer. It uses a CT scan to find cancer early, when it may be easier to treat.
This study uses a special endoscopic ultrasound to screen people at high risk for pancreatic cancer and follows them over time to catch cancer early or prevent it. If you have certain risk factors, you may be eligible to join.
This study is looking at healthy adults who have no symptoms or risk factors for pancreatic cancer to test a new imaging method that may help find early signs of the disease. If you join, you will have an endoscopic ultrasound (a thin tube with a camera passed to your stomach) to check your pancreas.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
Hear when a new Pancreatic Ductal Adenocarcinoma (PDAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.